ValuEngine upgraded shares of Innophos (NASDAQ:IPHS) from a strong sell rating to a sell rating in a report issued on Monday, February 4th.
Several other equities analysts also recently commented on IPHS. Zacks Investment Research downgraded Innophos from a hold rating to a strong sell rating in a research report on Thursday, October 25th. BidaskClub downgraded Innophos from a sell rating to a strong sell rating in a research report on Saturday, November 10th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the company. Innophos currently has a consensus rating of Hold and an average target price of $51.00.
IPHS stock opened at $33.58 on Monday. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.36 and a current ratio of 2.51. The stock has a market cap of $658.84 million, a price-to-earnings ratio of 14.73 and a beta of 1.38. Innophos has a 1-year low of $22.57 and a 1-year high of $50.40.
Innophos (NASDAQ:IPHS) last issued its quarterly earnings results on Wednesday, February 20th. The specialty chemicals company reported $0.54 EPS for the quarter, beating analysts’ consensus estimates of $0.51 by $0.03. The company had revenue of $192.74 million for the quarter, compared to analyst estimates of $189.60 million. Innophos had a return on equity of 13.39% and a net margin of 4.50%. The company’s quarterly revenue was down .2% compared to the same quarter last year. During the same period in the previous year, the company posted $0.52 earnings per share. Analysts predict that Innophos will post 2.23 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, March 15th. Shareholders of record on Friday, March 8th will be paid a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a yield of 5.72%. The ex-dividend date is Thursday, March 7th. Innophos’s payout ratio is presently 84.21%.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Public Employees Retirement System of Ohio increased its holdings in shares of Innophos by 14.1% during the fourth quarter. Public Employees Retirement System of Ohio now owns 2,708 shares of the specialty chemicals company’s stock worth $66,000 after buying an additional 334 shares in the last quarter. Great West Life Assurance Co. Can increased its holdings in Innophos by 1.4% in the fourth quarter. Great West Life Assurance Co. Can now owns 26,640 shares of the specialty chemicals company’s stock valued at $603,000 after purchasing an additional 364 shares during the period. Two Sigma Advisers LP increased its holdings in Innophos by 1.6% in the fourth quarter. Two Sigma Advisers LP now owns 31,538 shares of the specialty chemicals company’s stock valued at $774,000 after purchasing an additional 482 shares during the period. Texas Permanent School Fund increased its holdings in Innophos by 4.0% in the fourth quarter. Texas Permanent School Fund now owns 12,836 shares of the specialty chemicals company’s stock valued at $315,000 after purchasing an additional 499 shares during the period. Finally, Bank of Montreal Can increased its holdings in Innophos by 79.8% in the fourth quarter. Bank of Montreal Can now owns 1,300 shares of the specialty chemicals company’s stock valued at $32,000 after purchasing an additional 577 shares during the period. Hedge funds and other institutional investors own 88.30% of the company’s stock.
Innophos Holdings, Inc, together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. It operates through three segments: Food, Health and Nutrition; Industrial Specialties; and Other. The company's specialty ingredients include specialty phosphate salts and specialty phosphoric acids, as well as other mineral, enzyme, and botanical based specialty ingredients that are used as flavor enhancers in beverages; electrolytes in sports drinks; texture modifiers in cheeses; leavening agents in baked goods; calcium and phosphorus fortification in food and beverages; moisture and color retention in seafood, poultry, and meat; excipients in vitamins, minerals, nutritional supplements, and pharmaceuticals; and abrasives in toothpaste.
Recommended Story: Trading Strategy Examples and Plans
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Innophos Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos and related companies with MarketBeat.com's FREE daily email newsletter.